Senti Biosciences Inc. (SNTI)
3.03
0.02 (0.66%)
At close: Mar 03, 2025, 11:40 AM
Senti Biosciences Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 35.93M | 57.62M | 56.03M | 30.54M | 5.3M |
| Short-Term Investments | n/a | 40.94M | 1.16M | 25K | 12.53M |
| Long-Term Investments | 4.64M | 3.37M | 3.26M | n/a | n/a |
| Other Long-Term Assets | 2.03M | 293K | 176K | 497K | -16.59M |
| Receivables | 17.7M | 626K | 483K | 317K | 78K |
| Inventory | n/a | 3.29M | 2.6M | 25K | n/a |
| Other Current Assets | 17.57M | 3.39M | 3.68M | 855K | 853K |
| Total Current Assets | 71.2M | 102.58M | 60.19M | 31.71M | 18.76M |
| Property-Plant & Equipment | 41.61M | 74.55M | 33.08M | 16.14M | 16.59M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 48.28M | 78.21M | 36.51M | 16.64M | 16.59M |
| Total Assets | 119.48M | 180.79M | 96.7M | 48.34M | 35.84M |
| Account Payables | 1.25M | 1.37M | 5.19M | 914K | 1.2M |
| Deferred Revenue | 989K | 799K | 1.66M | 2M | n/a |
| Short-Term Debt | 4.13M | 3.98M | 1.74M | 1.52M | n/a |
| Other Current Liabilities | 6.3M | 11.91M | 5.96M | 2.43M | 3.11M |
| Total Current Liabilities | 12.67M | 18.05M | 14.54M | 4.87M | 4.31M |
| Long-Term Debt | 33.54M | 35.1M | 20.99M | 12.53M | n/a |
| Other Long-Term Liabilities | 6.36M | 373K | 172.45M | 89.66M | n/a |
| Total Long-Term Liabilities | 39.9M | 35.48M | 193.62M | 102.19M | n/a |
| Total Liabilities | 52.57M | 53.53M | 208.16M | 107.06M | 17.88M |
| Total Debt | 37.67M | 37.09M | 22.73M | 14.05M | n/a |
| Common Stock | 5K | 4K | 1K | 1K | 1K |
| Retained Earnings | -244.34M | -173.29M | -115.08M | -59.76M | -39.9M |
| Comprehensive Income | n/a | 1K | -171.83M | -89.66M | n/a |
| Shareholders Equity | 66.91M | 127.26M | -111.46M | -58.71M | 17.96M |
| Total Investments | 4.64M | 40.94M | 3.26M | 25K | 12.53M |